REQUEST A DEMO
Total
USD $0.00
Search more companies

Novo Nordisk Slovakia S.R.O. (Slovakia)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Novo Nordisk Slovakia S.R.O. Profile Updated: July 31, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Novo Nordisk Slovakia s.r.o. is the Slovak affiliate of Novo Nordisk, responsible for the distribution, marketing and regulatory support of the company's pharmaceutical portfolio. Its business segments focus on therapies for diabetes, obesity and rare endocrine and metabolic disorders, including modern insulins, antidiabetic agents and innovative treatments for chronic diseases. The company supplies hospitals, specialised centres, wholesalers and pharmacies nationwide. It is integrated into the company's European organisational structure, benefiting from global research, clinical development and medical education capabilities. Key assets include a strong therapeutic portfolio, institutional relationships within diabetology and endocrinology sectors and a long-standing global brand. Strategically, Novo Nordisk Slovakia aims to expand access to innovative chronic disease therapies, support patient education and strengthen cooperation with healthcare professionals to improve disease management outcomes.

Headquarters
ROSUM, Bajkalska, 19B
Bratislava; Bratislavsky; Postal Code: 82101

Contact Details: Purchase the Novo Nordisk Slovakia S.R.O. report to view the information.

Website: http://www.modrykruh.sk

Basic Information
Total Employees:
Purchase the Novo Nordisk Slovakia S.R.O. report to view the information.
Registered Capital:
Purchase the Novo Nordisk Slovakia S.R.O. report to view the information.
Financial Auditors:
Purchase the Novo Nordisk Slovakia S.R.O. report to view the information.
Incorporation Date:
March 16, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Attorney
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novo Nordisk Slovakia S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
27.48%
Total operating revenue
27.46%
Operating profit (EBIT)
32.11%
EBITDA
31.32%
Net Profit (Loss) for the Period
44.23%
Total Assets
38.37%
Total Equity
38.52%
Operating Profit Margin (ROS)
0.12%
Net Profit Margin
0.32%
Return on Equity (ROE)
2.84%
Debt/Equity
0.2%
Quick Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?